Kevin J. Anstrom, PhD

Director
University of North Carolina School of Public Health
Chapel Hill, North Carolina, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• LB1531A - Administration of abatacept, reduces mortality in hospitalized patients with COVID pneumonia. Results of a randomized controlled trial.

  Friday, October 21, 2022
  2:15 PM – 2:25 PM US ET

• LB1531B - Administration of the TNF-alpha inhibitor, infliximab, reduces mortality in hospitalized patients with COVID pneumonia. Results of a randomized controlled trial

  Friday, October 21, 2022
  2:15 PM – 2:25 PM US ET